7Baggers
 Denali Therapeutics stock holds Buy rating at Stifel amid FDA review  Investing.com Mon, 17 Nov 2025 15:15:00 GMT
 Bank of America Securities Remains a Buy on Denali Therapeutics (DNLI)  The Globe and Mail Sun, 16 Nov 2025 18:02:15 GMT
 The Escalator: Genentech, Denali Therapeutics, Eli Lilly and more  Medical Marketing and Media Thu, 13 Nov 2025 12:03:48 GMT
 Denali Therapeutics Stock Surges Amid Mixed Signals  TipRanks Tue, 11 Nov 2025 17:20:47 GMT
 Why Denali Therapeutics Shares Are Climbing  TipRanks Mon, 10 Nov 2025 15:47:24 GMT
 15 stocks set to explode in 2026  Insider Monkey Sun, 09 Nov 2025 20:15:44 GMT
 william blair maintains denali therapeutics(dnli.us) with buy rating  富途牛牛 Fri, 07 Nov 2025 19:29:22 GMT
 Lilly hires Denali executive to run neuroscience division  Endpoints News Fri, 07 Nov 2025 14:02:00 GMT
 Lilly bolsters leadership team with neuroscience and immunology in mind  European Pharmaceutical Review Fri, 07 Nov 2025 11:54:39 GMT
 denali therapeutics announces board and leadership changes by investing.com  Investing.com Nigeria Fri, 07 Nov 2025 10:19:31 GMT
 DNLI Posts Narrower-Than-Expected Q3 Loss, Advances MPS IIIA Drug  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 Decoding Denali Therapeutics Inc (DNLI): A Strategic SWOT Insigh  GuruFocus Fri, 07 Nov 2025 05:26:15 GMT
 td cowen maintains denali therapeutics(dnli.us) with buy rating  富途牛牛 Thu, 06 Nov 2025 23:31:00 GMT
 denali therapeutics q3 net loss widens to $126.9 mln  MarketScreener Thu, 06 Nov 2025 21:47:51 GMT
 denali therapeutics inc. announces board and executive changes  MarketScreener Thu, 06 Nov 2025 21:00:00 GMT
 Denali Therapeutics Announces Board and Executive Leadership Updates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Denali Therapeutics announces board and leadership changes  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 denali therapeutics reports q3 eps (74c), consensus (76c)  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Denali Therapeutics Shares Face Turbulence Amid Mixed Signals  TipRanks Wed, 05 Nov 2025 23:45:03 GMT
 price-driven insight from (dnli) for rule-based strategy  news.stocktradersdaily.com Wed, 05 Nov 2025 17:50:01 GMT
 denali therapeutics (nasdaq:dnli) price target raised to $26.00  MarketBeat Wed, 05 Nov 2025 15:42:21 GMT
 published on: 2025-11-05 05:24:14  newser.com Wed, 05 Nov 2025 11:24:14 GMT
 published on: 2025-11-05 04:56:02  newser.com Wed, 05 Nov 2025 10:56:02 GMT
 denali therapeutics earnings notes  Trefis Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-11-04 01:41:13  newser.com Tue, 04 Nov 2025 07:41:13 GMT
 denali therapeutics (dnli) shares cross below 200 dma  Nasdaq Mon, 03 Nov 2025 17:32:00 GMT

Denali Therapeutics Inc
(NASDAQ:DNLI) 

DNLI stock logo

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 that has completed Phase 1b clinical trials...

Founded: 2013
Full Time Employees: 281
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends